|

| 产地 | 中国 |
| 品牌 | Chemstan |
| 货号 | CS-P0301A |
| 用途 | 分析检测 |
| 包装规格 | 1mg |
| 纯度 | 99%% |
| CAS编号 | |
| 是否进口 | 否 |
SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor. | |
| In Vivo | Akita mice treated with 30 mg/kg LSKL have significantly increased nephrin expression, greater than twofold, compared with renal lysates from either saline controls or SLLK-treated mice[1] .TGF-β1 is significantly lower (0.10±0.01 pg/mL) in the plasma of mice receiving LSKL compared with that in plasma of mice receiving SLLK control peptide at day 42 (0.20±0.02 pg/mL; P=0.0001). MRNA expression is assessed in the suprarenal aortic lysates obtained from mice receiving SLLK and LSKL peptides[2] . MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
|---|---|
| Molecular Weight | 573.60 |
| Formula | C??H??F?N?O? |
| Sequence | Ser-Leu-Leu-Lys-NH2 |
| Sequence Shortening | SLLK-NH2 |
| Shipping | Room temperature in continental US; may vary elsewhere. |
| Storage | Powder-80°C2 years-20°C1 yearIn solvent-80°C6 months-20°C1 month |
| Solvent & Solubility | In Vitro: H2O : 135 mg/mL (235.36 mM; Need ultrasonic) Preparing ConcentrationSolventMass1 mg5 mg10 mg1 mM1.7434 mL8.7169 mL17.4338 mL5 mM0.3487 mL1.7434 mL3.4868 mL10 mM0.1743 mL0.8717 mL1.7434 mL * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
| References |
|